Phase III Completion + NIH ACTIV-5 Completion + EUA + OWS/BARDA + Car-T w Kite/Gilead interim look (Phase III may not be required) + BLA for Lenzilumab + kickoffs for CMML (Phase II) & GVHD (Phase 2/3) & Ifab in Glioblastoma (Phase I at full enrollment already) Trial's = a very, very busy 2021 for HGEN